A New Development in Early Breast Cancer Detection
Following her discovery that certain tumors appear on MRI before clinical diagnosis, Dr. Debbie Anabi began developing an AI-based technology capable of identifying these early lesions. Through a collaboration between Pinkstar and the Meirav Breast Center, this effort aims to improve early breast cancer detection.
Debbie Anabi, Head of the Breast Cancer Imaging Lab at Sheba Medical Center and CTO at Pinkstar, discovered that certain breast cancer lesions appeared on MRI before they became radiologically identifiable. Although visible within MRI resolution, these tumors were not suspected at the time. This finding motivated her to develop an AI-based technology capable of characterizing ultra-early lesions and predicting outcomes.
Implementing AI for Early Detection
Pinkstar, a company focused on developing AI technologies for breast MRI, aims to support earlier cancer detection.
Their system can successfully classify more than 65% of breast cancers one year before formal diagnosis in high-risk populations. The team highlights the complexity of breast MRI and the need for advanced tools to interpret early, subtle changes.
Pinkstar collaborates closely with the Meirav Breast Center at Sheba Medical Center, a unique facility that provides comprehensive breast cancer care under one roof. With the Meirav Center operating one of Israel’s leading breast radiology units, the collaboration provides access to clinical expertise and high-quality data through approximately 5,000 breast MRI scans performed annually, as well as the ongoing monitoring of thousands of high-risk women.
Moving Forward Together
Sheba Medical Center remains committed to innovation and collaboration as part of its mission to advance healthcare. Through partnerships like this one, Sheba actively works with leading organizations to explore new solutions, develop emerging technologies, and apply them in ways that improve patient care.
We would also like to take this opportunity to encourage all women reading this article to remain proactive about their health and to follow recommended screening guidelines. Early detection remains a critical factor in improving outcomes and saving lives.
More Posts
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
ARC Launches HaMeirim: Sheba’s New Cardiovascular Innovation Center
Sheba Medical Center’s ARC innovation arm has launched and inaugurated HaMeirim – ARC Cardiovascular (“The Radiant Ones” or “Those who shine”), a dedicated innovation center for the Heart, Thorax, and Vascular Center.
Understanding HIV, AIDS, and Prevention with Professor Itsik Levi
In a new “Doctor on Call” video, Professor Itsik Levi, director of the HIV and STDs clinic at Sheba Medical Center, addresses common questions about HIV and AIDS and highlights why early testing is so important. He explains that being HIV-positive means living with the virus, while AIDS refers to a stage of severe immune system damage in which the body can no longer fight off everyday infections.
